NovaBridge Biosciences (NBP) Shares Outstanding (Diluted Average) (2017 - 2025)

NovaBridge Biosciences (NBP) has 9 years of Shares Outstanding (Diluted Average) data on file, last reported at $220.3 million in Q4 2025.

• Quarterly Shares Outstanding (Diluted Average) changed N/A year-over-year to $220.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $220.3 million (changed N/A YoY) and the FY2025 annual result came in at $220.3 million, changed N/A from the prior year.
• Shares Outstanding (Diluted Average) rose to $220.3 million in Q4 2025 per NBP's latest filing, from $170.0 in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $220.3 million in Q4 2025 and bottomed at $110.0 in Q2 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $13.3 million (2023), against an average of $37.6 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Diluted Average) soared 6036364.12%; it then dropped 2.35% in 2022.
• Tracing NBP's Shares Outstanding (Diluted Average) over 5 years: stood at $27.3 million in 2021, then retreated by 2.35% to $26.7 million in 2022, then declined by 0.37% to $26.6 million in 2023, then tumbled by 100.0% to $140.0 in 2024, then surged by 157327708.57% to $220.3 million in 2025.
• Per Business Quant, the three latest NBP Shares Outstanding (Diluted Average) figures stand at $220.3 million (Q4 2025), $170.0 (Q3 2025), and $110.0 (Q2 2025).

Peer Comparison